331 related articles for article (PubMed ID: 36434109)
21. Diagnosis and clinical management of Wiskott-Aldrich syndrome: current and emerging techniques.
Cavannaugh C; Ochs HD; Buchbinder D
Expert Rev Clin Immunol; 2022 Jun; 18(6):609-623. PubMed ID: 35533396
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell transplantation for primary immunodeficiency diseases.
Slatter MA; Cant AJ
Ann N Y Acad Sci; 2011 Nov; 1238():122-31. PubMed ID: 22129059
[TBL] [Abstract][Full Text] [Related]
23. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Boztug K; Dewey RA; Klein C
Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
[TBL] [Abstract][Full Text] [Related]
24. Future of Therapy for Inborn Errors of Immunity.
Perez E
Clin Rev Allergy Immunol; 2022 Aug; 63(1):75-89. PubMed ID: 35020169
[TBL] [Abstract][Full Text] [Related]
25. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Patients in the Black Sea Region of Turkey.
Yıldıran A; Çeliksoy MH; Borte S; Güner ŞN; Elli M; Fışgın T; Özyürek E; Sancak R; Oğur G
Turk J Haematol; 2017 Dec; 34(4):345-349. PubMed ID: 28404538
[TBL] [Abstract][Full Text] [Related]
26. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
Front Immunol; 2018; 9():2554. PubMed ID: 30450104
[TBL] [Abstract][Full Text] [Related]
27. Gene therapy for the Wiskott-Aldrich syndrome.
Galy A; Thrasher AJ
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):545-50. PubMed ID: 21971332
[TBL] [Abstract][Full Text] [Related]
28. Genome editing for primary immunodeficiencies: A therapeutic perspective on Wiskott-Aldrich syndrome.
Naseem A; Steinberg Z; Cavazza A
Front Immunol; 2022; 13():966084. PubMed ID: 36059471
[TBL] [Abstract][Full Text] [Related]
29. Treatment of primary immunodeficiency with allogeneic transplant and gene therapy.
Pai SY
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):457-465. PubMed ID: 31808905
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitous high-level gene expression in hematopoietic lineages provides effective lentiviral gene therapy of murine Wiskott-Aldrich syndrome.
Astrakhan A; Sather BD; Ryu BY; Khim S; Singh S; Humblet-Baron S; Ochs HD; Miao CH; Rawlings DJ
Blood; 2012 May; 119(19):4395-407. PubMed ID: 22431569
[TBL] [Abstract][Full Text] [Related]
31. Gene therapy for Wiskott-Aldrich Syndrome.
Bosticardo M; Ferrua F; Cavazzana M; Aiuti A
Curr Gene Ther; 2014; 14(6):413-21. PubMed ID: 25245089
[TBL] [Abstract][Full Text] [Related]
32. Progress and prospects: gene therapy for inherited immunodeficiencies.
Qasim W; Gaspar HB; Thrasher AJ
Gene Ther; 2009 Nov; 16(11):1285-91. PubMed ID: 19776764
[TBL] [Abstract][Full Text] [Related]
33. Personalized hematopoietic stem cell transplantation for inborn errors of immunity.
Slatter M; Lum SH
Front Immunol; 2023; 14():1162605. PubMed ID: 37090739
[TBL] [Abstract][Full Text] [Related]
34. Stem-cell gene therapy for the Wiskott-Aldrich syndrome.
Boztug K; Schmidt M; Schwarzer A; Banerjee PP; Díez IA; Dewey RA; Böhm M; Nowrouzi A; Ball CR; Glimm H; Naundorf S; Kühlcke K; Blasczyk R; Kondratenko I; Maródi L; Orange JS; von Kalle C; Klein C
N Engl J Med; 2010 Nov; 363(20):1918-27. PubMed ID: 21067383
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.
Dupré L; Marangoni F; Scaramuzza S; Trifari S; Hernández RJ; Aiuti A; Naldini L; Roncarolo MG
Hum Gene Ther; 2006 Mar; 17(3):303-13. PubMed ID: 16544979
[TBL] [Abstract][Full Text] [Related]
36. The Primary Immune Deficiency Treatment Consortium: how can it improve definitive therapy for PID?
Cowan MJ
Expert Rev Clin Immunol; 2016 Oct; 12(10):1007-9. PubMed ID: 27454438
[No Abstract] [Full Text] [Related]
37. Gene therapy for Wiskott-Aldrich syndrome: History, new vectors, future directions.
Ferrua F; Marangoni F; Aiuti A; Roncarolo MG
J Allergy Clin Immunol; 2020 Aug; 146(2):262-265. PubMed ID: 32623069
[No Abstract] [Full Text] [Related]
38. How I manage patients with Wiskott Aldrich syndrome.
Rivers E; Worth A; Thrasher AJ; Burns SO
Br J Haematol; 2019 May; 185(4):647-655. PubMed ID: 30864154
[TBL] [Abstract][Full Text] [Related]
39. Gene Therapy Approaches to Immunodeficiency.
Ghosh S; Gaspar HB
Hematol Oncol Clin North Am; 2017 Oct; 31(5):823-834. PubMed ID: 28895850
[TBL] [Abstract][Full Text] [Related]
40. A possible turning point in the hematopoietic stem cell gene therapy for primary immunodeficiency diseases? Lentiviral vectors could take the place of retroviral vectors.
Ariga T
Expert Rev Clin Immunol; 2013 Nov; 9(11):1015-8. PubMed ID: 24168409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
